Kelie H. Luby

I first heard about Mint Medical in 2013 when a colleague said: ‘you have to see this software - this will change everything.’ At this time, I was part of the imaging Contract Research Organizations (iCROs) ecosystem, working in the area of imaging centrally read clinical trials, primarily in oncology. What my colleague and I realized was that mint Lesion™ allows you to ask for more.

Related Resources

Related Resources

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

RSNA 2025

11/30 to 12/03/2025 Chicago, Illinois

Annual Meeting of the Radiological Society of North America

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.

Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…